secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001493152-24-012133
Event type: earnings
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardion Health Sciences FY2023 revenue up 10.8% to $12.2M; selling main asset and planning dissolution
--------------------------------------------------------------------------------

- FY2023 revenue $12.2M (+10.8% YoY); net income $0.2M vs $(14.9M) loss prior year; EPS $0.12.
- Viactiv product line generated $11.9M (+11.9% YoY), representing 97.2% of total revenue.
- On Jan 30, 2024, agreed to sell Activ Nutritional (owner of Viactiv) for $17.2M cash, subject to stockholder approval.
- Board proposes voluntary dissolution and liquidation after sale closes; special meeting set for May 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224012133/0001493152-24-012133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224012133/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer